Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARCT | RVNC | SGMO | ||
| Company | Arcturus Therapeutics Ltd | Revance Therapeutics | Sangamo Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.08 | 4.18 | 2.07 | ||
| High | 17.37 | 4.19 | 2.17 | ||
| Low | 15.71 | 3.98 | 1.82 | ||
| Last | 16.45 | 4.00 | 1.93 | ||
| Change | +0.43 | -0.17 | -0.12 | ||
| % Change | +2.68% | -4.08% | -5.85% | ||
| Volume | 648,782 | 1,103,125 | 5,409,768 | ||
| 20-Day Average Volume | 411,038 | 2,792,771 | 15,809,948 | ||
| Previous Close | 16.02 | 4.17 | 2.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.66 | 5.06 | 2.07 | ||
| 20-Day Raw Stochastic | 19.16% | 22.89% | 38.69% | ||
| 20-Day Relative Strength | 35.82% | 36.94% | 54.83% | ||
| Weighted Alpha | -49.09 | -57.76 | -25.29 | ||
| Today's Opinion | 100% Sell | 8% Sell | 88% Buy | ||
| Previous Opinion | 100% Sell | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 64% Sell | 40% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.42% since 11/11/24 | +15.51% since 11/11/24 | -28.33% since 11/11/24 | ||
| Low | 14.93 on 11/15/24 | 3.42 on 11/12/24 | 1.82 on 11/18/24 | ||
| High | 20.07 on 11/12/24 | 4.36 on 11/14/24 | 2.86 on 11/12/24 | ||
| 1-Month | |||||
| %Chg | -23.36% since 10/18/24 | -24.67% since 10/18/24 | +110.17% since 10/18/24 | ||
| Low | 14.93 on 11/15/24 | 3.36 on 11/11/24 | 0.86 on 10/21/24 | ||
| High | 21.61 on 11/11/24 | 6.09 on 10/28/24 | 3.18 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | -19.75% since 08/16/24 | -39.80% since 08/16/24 | +119.89% since 08/16/24 | ||
| Low | 14.93 on 11/15/24 | 3.36 on 11/11/24 | 0.70 on 09/09/24 | ||
| High | 25.88 on 10/02/24 | 6.65 on 08/19/24 | 3.18 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | -45.57% since 05/17/24 | +31.95% since 05/17/24 | +197.88% since 05/17/24 | ||
| Low | 14.93 on 11/15/24 | 2.30 on 06/26/24 | 0.30 on 07/05/24 | ||
| High | 45.00 on 06/05/24 | 6.65 on 08/19/24 | 3.18 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 433,934 | 437,441 | 427,726 | ||
| Shares Outstanding, K | 27,087 | 104,902 | 208,647 | ||
| Annual Sales | 166,800,000 | 234,040,000 | 176,230,000 | ||
| Annual Net Income | -29,730,000 | -323,990,000 | -257,830,000 | ||
| Last Quarter Sales | 41,670,000 | 59,880,000 | 360,000 | ||
| Last Quarter Net Income | -6,900,000 | -38,120,000 | -36,130,000 | ||
| 60-Month Beta | 2.64 | 0.95 | 1.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 11/07/24 | -0.37 on 11/07/24 | 0.04 on 11/12/24 | ||
| Latest Earnings Date | 11/07/24 | 11/13/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 01/04/13 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||